Taconic's Dr. Alexander Maue recently authored a follow-up article for International Biopharmaceutical Industry (IBI) to his original comment on how the microbiome can improve reproducibility and translatability of animal models. In part two, he elaborates on how the microbiome can impact drug efficacy and what types of mouse models are being developed to further immuno-oncology research.
Read the complete article at: biopharmaceuticalmedia.com
Read the complete article at: biopharmaceuticalmedia.com